Glioma Susceptibility 1 C2750850
An inherited condition increasing risk of developing gliomas, a type of brain tumor. Family history is a key risk factor. Regular monitoring is recommended for early detection.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Persistent headache
New-onset seizures
Cognitive decline
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Personality changes
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Maximal Safe Surgical Resection
Aggressive but neurosurgically safe tumor resection to achieve maximal cytoreduction while preserving neurological function. Extent of resection is a key prognostic factor for outcomes.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Radiation Therapy
Focused radiation treatment targeting residual tumor cells following surgery, with modern techniques like proton beam therapy minimizing damage to surrounding healthy brain tissue.
Additional treatment options
Temozolomide Chemotherapy
Alkylating agent chemotherapy used as part of combined modality treatment, shown to improve outcomes when combined with radiation in high-grade glioma protocols.
medicationSerial Neuroimaging Surveillance
Regular MRI imaging to monitor treatment response, detect recurrence early, and assess for treatment-related changes including pseudoprogression and radiation necrosis.
monitoringIntegrative Supportive Care
Adjunctive therapies including acupuncture for pain management, massage for symptom relief, and mind-body practices to support quality of life during intensive cancer treatment.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Glioma Susceptibility 1 C2750850?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Glioma Susceptibility 1 C2750850. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy